Mel Max (Meloxicam)

Meloxicam works by reversibly inhibiting the cyclooxygenase enzymes COX‑1 and COX‑2, with a preference for COX‑2. This action lowers prostaglandin production, which are key mediators of inflammation, pain and fever, thereby providing anti‑inflammatory and analgesic effects.

The dosage of meloxicam is individualized by the prescribing clinician based on the patient’s condition, severity, age, renal and hepatic function, and other medications. Typical adult regimens range from low to moderate daily doses, but the exact amount must be determined by a qualified health professional.

Safety of meloxicam in pregnancy and lactation has not been established. It is generally advised to avoid use unless the potential benefit justifies the potential risk to the fetus or infant. Women who are pregnant, planning pregnancy, or breastfeeding should discuss alternatives with their healthcare provider.

To order Mel Max, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including any cold‑chain requirements) and necessary import documentation.

Meloxicam offers a longer half‑life and a higher selectivity for COX‑2 compared with many traditional NSAIDs, which may translate into once‑daily dosing and a potentially lower gastrointestinal risk profile. However, it shares class‑wide warnings such as cardiovascular and renal safety concerns, so individual risk assessment remains essential.

Mel Max should be stored at room temperature, below 25 °C, in its original packaging to protect it from moisture and light. Keep the product out of reach of children and do not use it after the expiry date printed on the label.

Mel Max is taken orally, usually with a full glass of water. It may be taken with or without food, but patients who experience stomach upset are often advised to take it with meals. Swallow the tablet whole; do not crush or chew unless specifically instructed by a healthcare professional.

Serious risks include gastrointestinal bleeding or ulceration, cardiovascular events such as heart attack or stroke, severe skin reactions (e.g., Stevens‑Johnson syndrome), liver injury, and renal impairment. Patients should seek immediate medical attention if they notice signs like black stools, chest pain, sudden swelling, rash, or decreased urine output.

Meloxicam is contraindicated in individuals with known hypersensitivity to meloxicam or other NSAIDs, those with active gastrointestinal ulceration or bleeding, severe heart failure, and patients who have had a recent coronary artery bypass graft. Caution is also advised for patients with significant renal or hepatic impairment.